A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

BACKGROUND: This multicenter, phase II trial tested the tolerability and efficacy of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma (FL). PATIENTS AND METHODS: Patients with grade 1–3a FL, stage 3–4 or bulky stage 2, FL international prognostic index (FLIPI) 0–...

詳細記述

保存先:
書誌詳細
出版年:Ann Oncol
主要な著者: Martin, P, Jung, S -H, Pitcher, B, Bartlett, N L, Blum, K A, Shea, T, Hsi, E D, Ruan, J, Smith, S E, Leonard, J P, Cheson, B D
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5789808/
https://ncbi.nlm.nih.gov/pubmed/28945884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx496
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料